These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 3971393)
1. NMU-1, a new transplantable mouse lung tumor: biological and chemosensitivity properties in vivo. Pratesi G; Pezzoni G; Parmiani G Cancer Treat Rep; 1985 Feb; 69(2):219-21. PubMed ID: 3971393 [TBL] [Abstract][Full Text] [Related]
2. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors. Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285 [TBL] [Abstract][Full Text] [Related]
3. Characterization and responsiveness of the Madison 109 lung carcinoma to various antitumor agents. Marks TA; Woodman RJ; Geran RI; Billups LH; Madison RM Cancer Treat Rep; 1977 Nov; 61(8):1459-70. PubMed ID: 922751 [TBL] [Abstract][Full Text] [Related]
4. Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice. Goto H; Yano S; Zhang H; Matsumori Y; Ogawa H; Blakey DC; Sone S Cancer Res; 2002 Jul; 62(13):3711-5. PubMed ID: 12097279 [TBL] [Abstract][Full Text] [Related]
5. [Establishment of human lung adenocarcinoma model in nude mice and sensitivity of the transplanted tumor to antitumor drugs]. Zhang SY; Dai ZQ; Shu YH; Zhang JL; Lin ZQ; Wu SF; Liu YF; Xu LZ Zhongguo Yao Li Xue Bao; 1987 Jul; 8(4):366-9. PubMed ID: 3445781 [No Abstract] [Full Text] [Related]
6. Evaluation of Madison 109 lung carcinoma as a model for screening antitumor drugs. Rose WC Cancer Treat Rep; 1981; 65(3-4):299-312. PubMed ID: 7237452 [TBL] [Abstract][Full Text] [Related]
7. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts. Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935 [TBL] [Abstract][Full Text] [Related]
8. Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model. Sigounas G; Sallah S; Sigounas VY Cancer Lett; 2004 Oct; 214(2):171-9. PubMed ID: 15363543 [TBL] [Abstract][Full Text] [Related]
9. [Induced resistance of experimental tumors to nitrosomethylurea]. Krutova TV; Ostrovskaia LA Vopr Onkol; 1982; 28(11):48-52. PubMed ID: 7147832 [TBL] [Abstract][Full Text] [Related]
10. Evidence of a direct relationship between the increase in the in vitro passage number of human non-small-cell-lung cancer primocultures and their chemosensitivity. Kruczynski A; Kiss R Anticancer Res; 1993; 13(2):507-13. PubMed ID: 7685990 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic studies of a transplantable murine renal adenocarcinoma. Sufrin G; Murphy GP Invest Urol; 1977 Jul; 15(1):9-14. PubMed ID: 68945 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug. Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972 [TBL] [Abstract][Full Text] [Related]
13. [Inhibition of river clam extract LX01 on human lung epithelial carcinoma cell line A549]. Wang SG; Li L Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):917-20. PubMed ID: 15321761 [TBL] [Abstract][Full Text] [Related]
14. Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin. Cai KX; Tse LY; Leung C; Tam PK; Xu R; Sham MH Clin Cancer Res; 2008 Feb; 14(3):939-49. PubMed ID: 18245558 [TBL] [Abstract][Full Text] [Related]
15. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile]. Hu S; Hu CP; Liang CH Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030 [TBL] [Abstract][Full Text] [Related]
16. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion. Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054 [TBL] [Abstract][Full Text] [Related]
17. Characterization of biological features and chemosensitivity of a new experimental lung metastasis model originating from the MXT mouse mammary adenocarcinoma. Farinelle S; Dedecker R; Malonne H; Werry J; Darro F; Kiss R Anticancer Res; 1999; 19(2A):1171-80. PubMed ID: 10368671 [TBL] [Abstract][Full Text] [Related]
18. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721 [TBL] [Abstract][Full Text] [Related]
19. 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Anzano MA; Smith JM; Uskoković MR; Peer CW; Mullen LT; Letterio JJ; Welsh MC; Shrader MW; Logsdon DL; Driver CL Cancer Res; 1994 Apr; 54(7):1653-6. PubMed ID: 8137276 [TBL] [Abstract][Full Text] [Related]
20. [Effects of suramin in combination with cisplatin on growth and metastasis of lung adenocarcinoma xenografts in mice]. Zhang P; He JB; Ou LW; Wang XH Ai Zheng; 2006 Apr; 25(4):409-13. PubMed ID: 16613671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]